Cells, Volume 12, Issue 14
2023 July-2 - 112 articles
Cover Story: The prominent pathological change in prion-affected brains is neuroinflammation and aggregation of pathogenic prions. We investigated the impact of innate immune responses on prion replication in vitro. Glial cells from the cerebellum were susceptible to HY, but resistant to DY prion as determined by Western blot analysis, immunocytochemistry, and animal bioassay. However, glial cells from the cerebral cortex were refractory to both strains. Priming glial cells with lipopolysaccharide decreased prion replication, whereas pre-treatment with dexamethasone inhibiting innate immunity increased susceptibility to DY infection. Our results suggest that neuroinflammation resulting from prion infection might be an attempt to resolve prion propagation, implying a therapeutic potential of innate immune modulation in the early stages of prion disease. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.